The Effect of (L-PRF) Membrane in The Treatment of Gingival Recession
NCT ID: NCT04224935
Last Updated: 2020-11-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2018-12-01
2020-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Group 1(10 patients) :
Coronally repositioned flap will be done and L PRF membrane will be placed into the tissues
Group 2 (Control group)(10 patients) :
Coronally repositioned flap will be done with sub epithelial connective tissue Parameters
* Clinical evaluation of percentage of root coverage and keratinized tissue width
* Esthetic outcome evaluation Will be done using the root coverage esthetic score (Cairo et al. 2009) that include
Both evaluations will be done at 3, 6 and 9 months
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Leukocyte Platelet Rich Fibrin
Leukocyte Platelet Rich Fibrin will be used
Leukocyte Platelet rich fibrin membrane
the use of Leukocyte Platelet rich fibrin as grafting materials for treatment of recession
connective tissue
connective tissue will be used
Leukocyte Platelet rich fibrin membrane
the use of Leukocyte Platelet rich fibrin as grafting materials for treatment of recession
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Leukocyte Platelet rich fibrin membrane
the use of Leukocyte Platelet rich fibrin as grafting materials for treatment of recession
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age range (20 -40) years.
* Good compliance with the plaque control instructions following initial therapy.
* Patients diagnosed with Miller class I or II in anterior and premolar teeth
* Availability for follow up and maintenance program.
Exclusion Criteria
* Presence of smoking habit.
* Presence of occlusion interference.
* Pregnant and lactating females.
* Vulnerable group of patients (handicapped, mentally retarded and prisoners).
20 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zainab Hafez Abdel Rahman
teaching assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ahmed abdel aziz, co professor
Role: STUDY_CHAIR
faculty of dentistry ain shams university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Dentistry Ain Shams University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
453
Identifier Type: -
Identifier Source: org_study_id